HK40112914A - Compounds and compositions for treating conditions associated with lpa receptor activity - Google Patents

Compounds and compositions for treating conditions associated with lpa receptor activity Download PDF

Info

Publication number
HK40112914A
HK40112914A HK62024100888.2A HK62024100888A HK40112914A HK 40112914 A HK40112914 A HK 40112914A HK 62024100888 A HK62024100888 A HK 62024100888A HK 40112914 A HK40112914 A HK 40112914A
Authority
HK
Hong Kong
Prior art keywords
compositions
compounds
conditions associated
receptor activity
treating conditions
Prior art date
Application number
HK62024100888.2A
Other languages
Chinese (zh)
Inventor
H·雷
Q·张
A·M·鲁文斯基
Original Assignee
罗特斯生物公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 罗特斯生物公司 filed Critical 罗特斯生物公司
Publication of HK40112914A publication Critical patent/HK40112914A/en

Links

HK62024100888.2A 2021-10-21 2022-10-21 Compounds and compositions for treating conditions associated with lpa receptor activity HK40112914A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNPCT/CN2021/125409 2021-10-21
CNPCT/CN2022/082072 2022-03-21

Publications (1)

Publication Number Publication Date
HK40112914A true HK40112914A (en) 2025-01-28

Family

ID=

Similar Documents

Publication Publication Date Title
IL316870A (en) Compounds for the targeted degradation of smarca2
EP3824892A4 (en) Composition for preventing or treating keloid or hypertrophic scar
EP3931336A4 (en) Compositions and methods for treating laminopathies
CA3253274A1 (en) Compounds and compositions for treating conditions associated with lpa receptor activity
EP4096675A4 (en) Compositions and methods for treating long covid
EP3911315A4 (en) Solid micronized melatonin composition
HK40112914A (en) Compounds and compositions for treating conditions associated with lpa receptor activity
HK40116022A (en) Compounds and compositions for treating conditions associated with lpa receptor activity
HK40098770A (en) Compounds and compositions for treating conditions associated with lpa receptor activity
HK40101053A (en) Compounds and compositions for treating conditions associated with lpa receptor activity
HK40119559A (en) Compounds and compositions for treating conditions associated with lpa receptor activity
HK40124083A (en) Compounds and compositions for treating conditions associated with lpa receptor activity
EP3984553A4 (en) Composition for preventing or treating cancer
IL310724A (en) Compounds and compositions for treating conditions associated with sting activity
EP4331665A4 (en) Composition for promoting lipolysis
HK40107251A (en) Compounds and compositions for treating conditions associated with sting activity
HK40107971A (en) Compounds and compositions for treating conditions associated with sting activity
HK40111930A (en) Compounds and compositions for treating conditions associated with sting activity
HK40102670A (en) Compounds and compositions for treating conditions associated with sting activity
HK40095051A (en) Compounds and compositions for treating conditions associated with sting activity
HK40072218A (en) Compounds and compositions for treating conditions associated with sting activity
HK40072216A (en) Compounds and compositions for treating conditions associated with sting activity
HK40115004A (en) Compounds and compositions for treating conditions associated with sting activity
HK40115006A (en) Compounds and compositions for treating conditions associated with sting activity
HK40061670B (en) Compounds and compositions for treating conditions associated with apj receptor activity